UK biotech
News/ News/ Sales and Marketing
Oxford Nanopore makes stellar debut on UK stock market
Phil Taylor
financing, Gene Sequencing, genomics, IPO, Oxford Nanopore, UK biotech
0 Comment
Dementia, cancer headline UK’s 10-year plan for life sciences sector
Phil Taylor
ABPI, BIA, Life Sciences, UK, UK biotech
0 Comment
R&D/ Views & Analysis/ Views and analysis
Clive Dix: Rebuilding UK biotech
Richard Staines
C4X Discovery, UK biotech, UK Leaders
0 Comment
UK biotech investment at record levels amid COVID-19
Phil Taylor
financing, investment, IPO, UK, UK biotech, venture capital
0 Comment
UK cancer mutation testing firm Biofidelity raises $12m
Phil Taylor
Biofidelity, diagnostics, financing, Molecular diagnostics, Oncology, UK biotech
0 Comment
Gene sequencing upstart Oxford Nanopore raises another $140m
Andrew McConaghie
Oxford Nanopore, UK biotech
0 Comment
Gene sequencing upstart Oxford Nanopore raises another $140m in its bid to enable the analysis of “any living thing, by anyone, anywhere.”